Beyond The Surface: Insights Into Psoriasis Pathophysiology and Therapy
Clicks: 6
ID: 309183
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
1.5
/100
6 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #49 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The autoimmune disease known as psoriasis affects 2-3 percent of all people worldwide while remaining as a continuous skin disorder. The clinical expressions from psoriasis adversely affect both physical health alongside mental wellness of patients. Pathogenesis arises via immune dysregulation that mostly affects keratinocyte proliferation through IL-23/Th17 axis activation. Genetic inheritances work together with environmental triggers as well as immune system responses to start and drive the development of diseases and progression. Medical professionals provide patients with mild psoriatic symptoms topical remedies yet systemic biologic drugs fight inflammatory cytokines in serious situations. A promising development emerges from JAK inhibitors and IL-23 antagonists which have become new therapeutic options. The study examines both the disease mechanism and medical approaches and new strategies for treating psoriasis.
| Reference Key |
imported_1761926612_6904ddd4497c0
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Gupta Aman Suresh, Sunita Thakur*, Vishakha Jaiswal |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2025 |
| DOI |
10.62896/ijpdd.2.4.4
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.